Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Carla Van Den Berg
Observed names:
C Van Den Berg,
Carla Van Berg
Institution:
The University of Texas at Austin
Observed institutions:
Livestrong Foundation,
The University of Texas at San Antonio Health Science Center,
The University of Texas at Austin
ORCID:
0000-0003-1156-7216
Observed ORCID:
0000-0003-1156-7216
OpenAlex ID:
A5040018768
Single-cell RNA sequencing of lung adenocarcinoma reveals heterogeneity of immune response–related genes
2019
·
Ke-Yue Ma
, Alexandra A. Schonnesen
, et al.
·
JCI Insight
·
79
Extracellular Matrix Stiffening Induces a Malignant Phenotypic Transition in Breast Epithelial Cells
2016
·
Ryan S. Stowers
, Shane C. Allen
, et al.
·
Cellular and Molecular Bioengineering
·
73
BCDIN3D RNA methyltransferase stimulates Aldolase C expression and glycolysis through let-7 microRNA in breast cancer cells
2021
·
Calder W. Reinsborough
, Hélène Ipas
, et al.
·
Oncogene
·
28
Covalent JNK Inhibitor, JNK-IN-8, Suppresses Tumor Growth in Triple-Negative Breast Cancer by Activating TFEB- and TFE3-Mediated Lysosome Biogenesis and Autophagy
2022
·
Milad Soleimani
, Alexander Somma
, et al.
·
Molecular Cancer Therapeutics
·
24
Use of hydroxyurea to alter drug resistance of human tumor cells
1995
·
Carla Van Den Berg
, Daniel D. Von Hoff
·
Cancer treatment and research
·
11
Elucidating the direct effects of the novel HDAC inhibitor bocodepsin (OKI-179) on T cells to rationally design regimens for combining with immunotherapy
2023
·
Nisha Holay
, Alexander Somma
, et al.
·
Frontiers in Immunology
·
9
Single Cell RNA Sequencing of Lung Adenocarcinoma Reveals Heterogeneity of Immune Response-related Genes
2018
·
Keyue Ma
, Alexandra A Schonnesen
, et al.
·
The Journal of Immunology
·
4
Transcription factor EB (TFEB) activity increases resistance of TNBC stem cells to metabolic stress
2025
·
Milad Soleimani
, Mark Duchow
, et al.
·
Life Science Alliance
·
3
PDF
Abstract 4109: Covalent JNK inhibitor, JNK-IN-8, suppresses tumor growth in triple-negative breast cancer in part by activating lysosome biogenesis and autophagy via TFEB and TFE3
2022
·
Milad Soleimani
, Tamer Kaoud
, et al.
·
Cancer Research
·
1
JNK2 enhances mammary carcinoma cell migration by regulating EPS8 expression and localization.
2009
·
S Mitra
, C Van Den Berg
·
Cancer Research
·
1
American Association for Cancer Research April 20-24, 1996
1996
·
Carla Van Den Berg
·
Journal of Oncology Pharmacy Practice
·
1
Supplementary Data from Covalent JNK Inhibitor, JNK-IN-8, Suppresses Tumor Growth in Triple-Negative Breast Cancer by Activating TFEB- and TFE3-Mediated Lysosome Biogenesis and Autophagy
2023
·
Milad Soleimani
, Alexander Somma
, et al.
Supplementary Data from Covalent JNK Inhibitor, JNK-IN-8, Suppresses Tumor Growth in Triple-Negative Breast Cancer by Activating TFEB- and TFE3-Mediated Lysosome Biogenesis and Autophagy
2023
·
Milad Soleimani
, Alexander Somma
, et al.
PDF
Supplementary Data from Covalent JNK Inhibitor, JNK-IN-8, Suppresses Tumor Growth in Triple-Negative Breast Cancer by Activating TFEB- and TFE3-Mediated Lysosome Biogenesis and Autophagy
2023
·
Milad Soleimani
, Alexander Somma
, et al.
PDF
Supplementary Data from Covalent JNK Inhibitor, JNK-IN-8, Suppresses Tumor Growth in Triple-Negative Breast Cancer by Activating TFEB- and TFE3-Mediated Lysosome Biogenesis and Autophagy
2023
·
Milad Soleimani
, Alexander Somma
, et al.
PDF
Supplementary Data from Covalent JNK Inhibitor, JNK-IN-8, Suppresses Tumor Growth in Triple-Negative Breast Cancer by Activating TFEB- and TFE3-Mediated Lysosome Biogenesis and Autophagy
2023
·
Milad Soleimani
, Alexander Somma
, et al.
Supplementary Data from Covalent JNK Inhibitor, JNK-IN-8, Suppresses Tumor Growth in Triple-Negative Breast Cancer by Activating TFEB- and TFE3-Mediated Lysosome Biogenesis and Autophagy
2023
·
Milad Soleimani
, Alexander Somma
, et al.
Supplementary Data from Covalent JNK Inhibitor, JNK-IN-8, Suppresses Tumor Growth in Triple-Negative Breast Cancer by Activating TFEB- and TFE3-Mediated Lysosome Biogenesis and Autophagy
2023
·
Milad Soleimani
, Alexander Somma
, et al.
Supplementary Data from Covalent JNK Inhibitor, JNK-IN-8, Suppresses Tumor Growth in Triple-Negative Breast Cancer by Activating TFEB- and TFE3-Mediated Lysosome Biogenesis and Autophagy
2023
·
Milad Soleimani
, Alexander Somma
, et al.
PDF
Supplementary Data from Covalent JNK Inhibitor, JNK-IN-8, Suppresses Tumor Growth in Triple-Negative Breast Cancer by Activating TFEB- and TFE3-Mediated Lysosome Biogenesis and Autophagy
2023
·
Milad Soleimani
, Alexander Somma
, et al.
Supplementary Data from Covalent JNK Inhibitor, JNK-IN-8, Suppresses Tumor Growth in Triple-Negative Breast Cancer by Activating TFEB- and TFE3-Mediated Lysosome Biogenesis and Autophagy
2023
·
Milad Soleimani
, Alexander Somma
, et al.
Supplementary Data from Covalent JNK Inhibitor, JNK-IN-8, Suppresses Tumor Growth in Triple-Negative Breast Cancer by Activating TFEB- and TFE3-Mediated Lysosome Biogenesis and Autophagy
2023
·
Milad Soleimani
, Alexander Somma
, et al.
PDF
Supplementary Data from Covalent JNK Inhibitor, JNK-IN-8, Suppresses Tumor Growth in Triple-Negative Breast Cancer by Activating TFEB- and TFE3-Mediated Lysosome Biogenesis and Autophagy
2023
·
Milad Soleimani
, Alexander Somma
, et al.
Data from Covalent JNK Inhibitor, JNK-IN-8, Suppresses Tumor Growth in Triple-Negative Breast Cancer by Activating TFEB- and TFE3-Mediated Lysosome Biogenesis and Autophagy
2023
·
Milad Soleimani
, Alexander Somma
, et al.
Data from Covalent JNK Inhibitor, JNK-IN-8, Suppresses Tumor Growth in Triple-Negative Breast Cancer by Activating TFEB- and TFE3-Mediated Lysosome Biogenesis and Autophagy
2023
·
Milad Soleimani
, Alexander Somma
, et al.
Show more works
View as search
Works count:
33
Citation count:
234
H-index:
6
I10-index:
5
Year
Topic
Type